Advanced
  Home Compare Reports

Comparison with Similar Reports

Laparoscopic Instruments Market by Product (Laparoscope, Insufflator, Suction/Irrigation systems, Access & Energy Devices), Application (Gynecology, G...

Publisher:        MarketsandMarkets

# of Pages:        251

Rating: 

1 User License $4,950

Publication Date:  April, 2021

Price:       $4,950 / User License




1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 31
1.3 MARKET SCOPE 31
1.3.1 MARKETS COVERED 31
1.3.2 YEARS CONSIDERED FOR THE STUDY 32
1.3.3 CURRENCY 32
1.3.4 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 32
1.4 LIMITATIONS 32
1.5 STAKEHOLDERS 33
1.6 SUMMARY OF CHANGES 33
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 1 RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 37
FIGURE 2 PRIMARY SOURCES 37
2.1.2.1 Key data from primary sources 38
2.1.2.2 Key industry insights 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-
SIDE PARTICIPANTS 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 41
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION 41
FIGURE 7 REVENUE ANALYSIS OF THE TOP 5 COMPANIES: LAPAROSCOPIC INSTRUMENTS MARKET (2020) 42
FIGURE 8 DEMAND-SIDE ANALYSIS 43
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 44
FIGURE 10 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE LAPAROSCOPIC INSTRUMENTS MARKET (2021–2026) 44
FIGURE 11 TOP-DOWN APPROACH 45
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 46
FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY 46
2.4 MARKET SHARE ANALYSIS 47
2.5 ASSUMPTIONS FOR THE STUDY 47
2.6 LIMITATIONS 47
2.7 RISK ASSESSMENT 48
TABLE 1 RISK ASSESSMENT: LAPAROSCOPIC INSTRUMENTS MARKET 48
2.8 COVID-19 HEALTH ASSESSMENT 48
2.9 COVID-19 ECONOMIC ASSESSMENT 49
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 49
FIGURE 13 CRITERIA IMPACTING THE GLOBAL ECONOMY 49
FIGURE 14 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 51
2.11 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LAPAROSCOPIC INSTRUMENTS MARKET 52
3 EXECUTIVE SUMMARY 53
FIGURE 15 LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2021 VS. 2026 53
FIGURE 16 LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION, 2021 VS. 2026 54
FIGURE 17 LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER, 2021 VS. 2026 54
FIGURE 18 GEOGRAPHIC SNAPSHOT: LAPAROSCOPIC INSTRUMENTS MARKET 55
4 PREMIUM INSIGHTS 57
4.1 LAPAROSCOPIC INSTRUMENTS MARKET OVERVIEW 57
FIGURE 19 INCREASED ADOPTION OF MINIMALLY INVASIVE SURGERIES OVER OPEN SURGERIES TO DRIVE MARKET GROWTH 57
4.2 ASIA PACIFIC: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION 58
FIGURE 20 GENERAL SURGERY SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE APAC MARKET 58
4.3 LAPAROSCOPIC INSTRUMENTS MARKET: GEOGRAPHIC MIX 59
FIGURE 21 US TO WITNESS THE HIGHEST GROWTH IN THE LAPAROSCOPIC INSTRUMENTS MARKET DURING THE FORECAST PERIOD 59
5 MARKET OVERVIEW 60
5.1 INTRODUCTION 60
5.2 MARKET DYNAMICS 60
FIGURE 22 LAPAROSCOPIC INSTRUMENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 60
5.2.1 MARKET DRIVERS 61
5.2.1.1 Increasing adoption of minimally invasive surgeries over open surgeries 61
5.2.1.2 Rising prevalence of colorectal cancer 61
FIGURE 23 GROWTH ESTIMATES FOR THE NUMBER OF NEW COLORECTAL CANCER CASES ACROSS THE GLOBE, 2020–2040 62
5.2.1.3 Increasing number of laparoscopic bariatric procedures 62
FIGURE 24 US: GROWTH IN THE NUMBER OF BARIATRIC SURGERIES, 2011–2018 63
TABLE 2 NUMBER OF BARIATRIC SURGERIES PERFORMED WORLDWIDE IN 2018 63
 
5.2.1.4 Technological advancements in the field of laparoscopy 64
TABLE 3 TECHNOLOGICAL ADVANCEMENTS IN LAPAROSCOPIC INSTRUMENTS 64
5.2.2 MARKET RESTRAINTS 65
5.2.2.1 Reduced Medicare payments to healthcare providers in the US 65
TABLE 4 MEDICARE PAYMENTS FOR LAPAROSCOPIC PROCEDURES, 2015 VS. 2020 65
5.2.2.2 Dearth of trained professionals in the field of laparoscopy 66
TABLE 5 US: TOTAL NUMBER OF SURGEONS (2010–2017) 66
5.2.3 MARKET OPPORTUNITIES 66
5.2.3.1 Growing healthcare markets in emerging economies 66
5.2.3.2 Enhancements in the capabilities of laparoscopic instruments 67
5.2.4 MARKET CHALLENGES 67
5.2.4.1 Product recalls 67
TABLE 6 LIST OF PRODUCT RECALLS 67
5.2.4.2 Gaps in infrastructural support for laparoscopic procedures in developing countries 68
5.3 NUMBER OF LAPAROSCOPIC PROCEDURES 69
5.3.1 NUMBER OF LAPAROSCOPIC COLECTOMY PROCEDURES,
BY COUNTRY/REGION, 2014–2018 69
5.3.2 NUMBER OF LAPAROSCOPIC APPENDECTOMY PROCEDURES,
BY COUNTRY/REGION, 2014–2018 69
5.3.3 NUMBER OF LAPAROSCOPIC CHOLECYSTECTOMY PROCEDURES,
BY COUNTRY/REGION, 2014–2018 70
5.3.4 NUMBER OF LAPAROSCOPIC INGUINAL HERNIA REPAIR PROCEDURES,
BY COUNTRY/REGION, 2014–2018 70
5.3.5 NUMBER OF LAPAROSCOPIC HYSTERECTOMY PROCEDURES,
BY COUNTRY/REGION, 2014–2018 71
5.4 PRICING ANALYSIS 71
FIGURE 25 AVERAGE SELLING PRICE CONTRIBUTION OF VARIOUS COMPONENTS IN A FLEXIBLE LAPAROSCOPE 71
FIGURE 26 AVERAGE SELLING PRICE CONTRIBUTION OF VARIOUS COMPONENTS IN A RIGID LAPAROSCOPE 72
TABLE 7 VARIOUS SPECIFICATIONS FOR LAPAROSCOPES 72
TABLE 8 AVERAGE SELLING PRICE OF LAPAROSCOPES 72
5.5 VALUE CHAIN ANALYSIS 73
FIGURE 27 LAPAROSCOPIC INSTRUMENTS MARKET: VALUE CHAIN ANALYSIS 73
5.6 ECOSYSTEM MARKET MAP 73
FIGURE 28 LAPAROSCOPIC INSTRUMENTS MARKET: ECOSYSTEM MARKET MAP 74
5.7 PORTER’S FIVE FORCES ANALYSIS 74
TABLE 9 LAPAROSCOPIC INSTRUMENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 74
5.7.1 INTENSITY OF COMPETITIVE RIVALRY 74
5.7.2 BARGAINING POWER OF SUPPLIERS 75
5.7.3 BARGAINING POWER OF BUYERS 75
5.7.4 THREAT OF SUBSTITUTES 75
5.7.5 THREAT OF NEW ENTRANTS 75
5.8 SUPPLY CHAIN ANALYSIS 76
FIGURE 29 LAPAROSCOPIC INSTRUMENTS MARKET: SUPPLY CHAIN ANALYSIS 77
5.9 IMPACT OF COVID-19 ON THE LAPAROSCOPIC INSTRUMENTS MARKET 77
5.10 REGULATORY ANALYSIS 78
5.10.1 NORTH AMERICA 78
5.10.1.1 US 78
TABLE 10 US FDA: MEDICAL DEVICE CLASSIFICATION 78
TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 78
5.10.1.2 Canada 79
TABLE 12 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 79
FIGURE 30 CANADA: CLASS II MEDICAL DEVICES APPROVAL PROCESS 79
5.10.2 EUROPE 80
FIGURE 31 EUROPE: CE APPROVAL PROCESS FOR CLASS IIA MEDICAL DEVICES 80
5.10.3 ASIA PACIFIC 80
5.10.3.1 Japan 80
TABLE 13 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 81
5.10.3.2 China 81
TABLE 14 CHINA: REGULATORY BODIES APPOINTED FOR MEDICAL DEVICE APPROVAL 81
TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES 82
5.10.3.3 India 82
5.11 PATENT ANALYSIS 83
5.11.1 PATENT PUBLICATION TRENDS FOR LAPAROSCOPES 83
FIGURE 32 PATENT PUBLICATION TRENDS (2015–2020) 83
5.11.2 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR LAPAROSCOPE PATENTS 84
FIGURE 33 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR LAPAROSCOPE PATENTS (2015–2021) 84
5.11.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR LAPAROSCOPE PATENTS 85
FIGURE 34 TOP APPLICANT COUNTRIES FOR LAPAROSCOPE PATENTS (2015–2021) 85
5.12 TECHNOLOGICAL ANALYSIS 85
5.12.1 KEY TECHNOLOGY 85
5.12.1.1 Application of vision systems 85
5.12.1.2 Complementary technology 86
5.12.1.2.1 Robot-assisted surgeries 86
5.12.1.3 Adjacent technology 86
5.12.1.3.1 Haptic and sensory feedback 86
5.13 TREND ANALYSIS 87
TABLE 16 SOME OF THE IMPORT/EXPORT TRADES RELATED TO LAPAROSCOPES 87
 
6 LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT 88
6.1 INTRODUCTION 89
TABLE 17 LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 89
6.2 MEDICAL LAPAROSCOPIC ROBOTS 89
6.2.1 MEDICAL ROBOTS ACCOUNTED FOR THE LARGEST SHARE IN THE LAPAROSCOPIC INSTRUMENTS MARKET IN 2020 89
TABLE 18 MEDICAL LAPAROSCOPIC ROBOTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 90
6.3 LAPAROSCOPES 91
TABLE 19 LAPAROSCOPES AVAILABLE IN THE MARKET 91
FIGURE 35 LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 92
TABLE 20 LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 92
TABLE 21 LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (THOUSAND UNITS) 92
TABLE 22 LAPAROSCOPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 93
TABLE 23 LAPAROSCOPES MARKET, BY REGION, 2019–2026 (THOUSAND UNITS) 93
6.3.1 VIDEO LAPAROSCOPES 94
6.3.1.1 Video laparoscopes dominate the laparoscopes market 94
TABLE 24 VIDEO LAPAROSCOPES AVAILABLE IN THE MARKET 94
TABLE 25 VIDEO LAPAROSCOPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 94
TABLE 26 VIDEO LAPAROSCOPES MARKET, BY REGION,
2019–2026 (THOUSAND UNITS) 95
6.3.2 FIBER LAPAROSCOPES 95
6.3.2.1 High-definition imaging capabilities drive the growth of the fiber laparoscopes market 95
TABLE 27 LAPAROSCOPES AVAILABLE IN THE MARKET 95
TABLE 28 FIBER LAPAROSCOPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 96
TABLE 29 FIBER LAPAROSCOPES MARKET, BY REGION,
2019–2026 (THOUSAND UNITS) 96
6.4 ENERGY DEVICES 97
6.4.1 INCREASING DEMAND FOR REUSABLE MONOPOLAR AND BIPOLAR COAGULATION ENERGY DEVICES DRIVES THE MARKET GROWTH 97
TABLE 30 ENERGY DEVICES AVAILABLE IN THE MARKET 97
TABLE 31 ENERGY DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 98
6.5 CLOSURE DEVICES 98
6.5.1 TECHNOLOGICAL ADVANCEMENTS IN CLOSURE DEVICES DRIVES
MARKET GROWTH 98
TABLE 32 CLOSURE DEVICES AVAILABLE IN THE MARKET 99
TABLE 33 CLOSURE DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 99
6.6 HAND INSTRUMENTS 100
6.6.1 INCREASING NUMBER OF GENERAL LAPAROSCOPIC SURGERIES DRIVE THE GROWTH OF HAND INSTRUMENTS 100
TABLE 34 HAND INSTRUMENTS AVAILABLE IN THE MARKET 102
TABLE 35 HAND INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 102
6.7 ACCESS DEVICES 103
6.7.1 ACCESS DEVICES ARE REQUIRED TO CREATE AND MAINTAIN PORTS OF ENTRANCE FOR OTHER INSTRUMENTS 103
TABLE 36 ACCESS DEVICES AVAILABLE IN THE MARKET 103
TABLE 37 ACCESS DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 104
6.8 ACCESSORIES 104
6.8.1 INCREASING SURGICAL VOLUMES DRIVE DEMAND FOR ACCESSORIES 104
TABLE 38 LAPAROSCOPIC ACCESSORIES & THEIR FUNCTIONALITIES 105
TABLE 39 LAPAROSCOPIC ACCESSORIES AVAILABLE IN THE MARKET 105
TABLE 40 LAPAROSCOPIC ACCESSORIES MARKET, BY COUNTRY,
2019–20206 (USD MILLION) 106
6.9 INSUFFLATORS 107
6.9.1 RISING NUMBER OF LAPAROSCOPIC SURGERIES PERFORMED BOOSTS THE MARKET FOR CO2 INSUFFLATORS 107
TABLE 41 INSUFFLATORS AVAILABLE IN THE MARKET 107
TABLE 42 INSUFFLATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 108
TABLE 43 INSUFFLATORS MARKET, BY REGION, 2019–2026 (THOUSAND UNITS) 108
6.10 SUCTION/IRRIGATION SYSTEMS 109
6.10.1 GROWING TREND TOWARD INTEGRATED FLUID MANAGEMENT SYSTEMS FOR LAPAROSCOPIC PROCEDURES DRIVES THE MARKET GROWTH 109
TABLE 44 SUCTION/IRRIGATION SYSTEMS AVAILABLE IN THE MARKET 109
TABLE 45 SUCTION/IRRIGATION SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 110
7 LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION 111
7.1 INTRODUCTION 112
TABLE 46 LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 112
7.2 GENERAL SURGERY 112
7.2.1 PREFERENCE FOR LAPAROSCOPY TECHNIQUES IS INCREASING IN APPENDECTOMY, CHOLECYSTECTOMY, AND HERNIA REPAIR 112
TABLE 47 EVOLUTION OF LAPAROSCOPY FOR COMMON PROCEDURES IN GENERAL SURGERY 113
TABLE 48 LAPAROSCOPIC CHOLECYSTECTOMY PROCEDURES PERFORMED IN HOSPITALS (PER 100,000 INHABITANTS), BY COUNTRY, 2018 113
TABLE 49 LAPAROSCOPIC INGUINAL HERNIA REPAIR AND APPENDECTOMY PROCEDURES PERFORMED IN HOSPITALS (PER 100,000 INHABITANTS),
BY COUNTRY, 2013 VS. 2018 114
TABLE 50 LAPAROSCOPIC INSTRUMENTS MARKET FOR GENERAL SURGERY,
BY COUNTRY, 2019–2026 (USD MILLION) 115
7.3 GYNECOLOGICAL SURGERY 115
7.3.1 THE NUMBER OF LAPAROSCOPIC HYSTERECTOMIES HAS INCREASED IN RECENT YEARS 115
TABLE 51 LAPAROSCOPIC HYSTERECTOMY PROCEDURES PERFORMED IN HOSPITALS (PER 100,000 INHABITANTS), BY COUNTRY, 2013 VS. 2018 116
TABLE 52 LAPAROSCOPIC INSTRUMENTS MARKET FOR GYNECOLOGICAL SURGERY,
BY COUNTRY, 2019–2026 (USD MILLION) 117
7.4 COLORECTAL SURGERY 117
7.4.1 INCREASING INCIDENCE OF COLORECTAL CANCER ACROSS THE GLOBE TO DRIVE MARKET GROWTH 117
TABLE 53 ESTIMATED NUMBER OF NEW CASES OF COLON, RECTAL, AND ANAL CANCER, BY REGION, 2020 VS. 2040 (THOUSAND) 118
TABLE 54 LAPAROSCOPIC INSTRUMENTS MARKET FOR COLORECTAL SURGERY,
BY COUNTRY, 2019–2026 (USD MILLION) 119
7.5 BARIATRIC SURGERY 119
7.5.1 ADVANCEMENTS IN LAPAROSCOPIC TECHNIQUES TO IMPROVE BARIATRIC SURGICAL OUTCOMES TO DRIVE MARKET GROWTH 119
FIGURE 36 GROWTH IN THE NUMBER OF LAPAROSCOPIC SLEEVE GASTRECTOMY SURGICAL PROCEDURES IN THE US, 2011–2019 120
TABLE 55 LAPAROSCOPIC INSTRUMENTS MARKET FOR BARIATRIC SURGERY,
BY COUNTRY, 2019–2026 (USD MILLION) 120
7.6 UROLOGICAL SURGERY 121
7.6.1 INCREASING INCIDENCE OF UROLOGICAL DISEASES TO DRIVE MARKET GROWTH 121
TABLE 56 LAPAROSCOPIC INSTRUMENTS MARKET FOR UROLOGICAL SURGERY,
BY COUNTRY, 2019–2026 (USD MILLION) 122
7.7 PEDIATRIC SURGERY 122
7.7.1 LAPAROSCOPIC SURGICAL PROCEDURES FOR PEDIATRIC APPLICATIONS HAVE WITNESSED SLOWER ADOPTION 122
TABLE 57 LAPAROSCOPIC INSTRUMENTS MARKET FOR PEDIATRIC SURGERY,
BY COUNTRY, 2019–2026 (USD MILLION) 123
8 LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER 124
8.1 INTRODUCTION 125
TABLE 58 LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 125
8.2 HOSPITALS 125
8.2.1 HOSPITALS ARE THE LARGEST END USERS OF LAPAROSCOPIC INSTRUMENTS 125
TABLE 59 LAPAROSCOPIC INSTRUMENTS MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION) 126
8.3 AMBULATORY SURGICAL CENTERS 127
8.3.1 INCREASING NUMBER OF CENTERS WILL DRIVE THE MARKET GROWTH 127
TABLE 60 MEDICARE REIMBURSEMENT RATES FOR LAPAROSCOPIC PROCEDURES FOR AMBULATORY SURGICAL CENTERS AND HOSPITALS IN 2021 127
TABLE 61 LAPAROSCOPIC INSTRUMENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2019–2026 (USD MILLION) 129
9 LAPAROSCOPIC INSTRUMENTS MARKET, BY REGION 130
9.1 INTRODUCTION 131
TABLE 62 LAPAROSCOPIC INSTRUMENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 131
FIGURE 37 EMERGING COUNTRIES ARE EXPECTED TO WITNESS HIGHER GROWTH IN THE FORECAST PERIOD 132
 
9.2 NORTH AMERICA 132
9.2.1 NORTH AMERICA: IMPACT OF COVID-19 ON THE LAPAROSCOPIC INSTRUMENTS MARKET 133
FIGURE 38 NORTH AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET SNAPSHOT 134
TABLE 63 NORTH AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 134
TABLE 64 NORTH AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 135
TABLE 65 NORTH AMERICA: LAPAROSCOPES MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
TABLE 66 NORTH AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 136
TABLE 67 NORTH AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION) 136
9.2.2 US 136
9.2.2.1 The US dominates the global laparoscopic instruments market 136
TABLE 68 US: KEY MACROINDICATORS 137
TABLE 69 US: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 138
TABLE 70 US: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 138
TABLE 71 US: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 138
TABLE 72 US: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 139
9.2.3 CANADA 139
9.2.3.1 Unfavorable regulatory processes in Canada to restrain the market growth 139
TABLE 73 AGE-STANDARDIZED INCIDENCE RATES (ASIR) FOR SELECTED CANCERS IN CANADA, 2015 VS. 2017 140
TABLE 74 CANADA: KEY MACROINDICATORS 141
TABLE 75 CANADA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 141
TABLE 76 CANADA: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 141
TABLE 77 CANADA: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 142
TABLE 78 CANADA: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 142
9.3 EUROPE 142
9.3.1 EUROPE: IMPACT OF COVID-19 ON THE LAPAROSCOPIC INSTRUMENTS MARKET 143
TABLE 79 EUROPE: LAPAROSCOPIC INSTRUMENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 143
TABLE 80 EUROPE: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 144
TABLE 81 EUROPE: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 82 EUROPE: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 145
TABLE 83 EUROPE: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 145
9.3.2 GERMANY 145
9.3.2.1 Germany to dominate the European market for laparoscopic instruments during the forecast period 145
TABLE 84 GERMANY: KEY MACROINDICATORS 146
TABLE 85 GERMANY: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 146
TABLE 86 GERMANY: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 87 GERMANY: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 147
TABLE 88 GERMANY: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 147
9.3.3 FRANCE 148
9.3.3.1 Favorable health insurance system to drive the market for laparoscopic instruments in France 148
TABLE 89 FRANCE: KEY MACROINDICATORS 148
TABLE 90 FRANCE: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 149
TABLE 91 FRANCE: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 92 FRANCE: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 150
TABLE 93 FRANCE: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 150
9.3.4 UK 150
9.3.4.1 Investments by hospitals in laparoscopy infrastructure to drive market growth in the UK 150
TABLE 94 UK: KEY MACROINDICATORS 151
TABLE 95 UK: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 152
TABLE 96 UK: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 152
TABLE 97 UK: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 152
TABLE 98 UK: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 153
9.3.5 ITALY 153
9.3.5.1 Growing cancer incidence and the number of related diagnostic and therapeutic surgical procedures to drive market growth 153
TABLE 99 ITALY: KEY MACROINDICATORS 153
TABLE 100 ITALY: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 154
TABLE 101 ITALY: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 102 ITALY: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 155
TABLE 103 ITALY: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 155
 
9.3.6 SPAIN 155
9.3.6.1 Rising number of surgical procedures to drive market growth 155
TABLE 104 SPAIN: KEY MACROINDICATORS 156
TABLE 105 SPAIN: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 156
TABLE 106 SPAIN: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 107 SPAIN: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 157
TABLE 108 SPAIN: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 157
9.3.7 REST OF EUROPE 158
TABLE 109 LAPAROSCOPIC COLECTOMY, APPENDECTOMY, AND CHOLECYSTECTOMY PROCEDURES IN EUROPE, 2018 (PER 100,000 INHABITANTS) 158
TABLE 110 LAPAROSCOPIC HYSTERECTOMY SURGERIES IN EUROPE (2008 TO 2018) 159
TABLE 111 LAPAROSCOPIC REPAIR OF INGUINAL SURGERIES IN EUROPE
(2013 TO 2018) 160
TABLE 112 ROE: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 161
TABLE 113 ROE: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 162
TABLE 114 ROE: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 162
TABLE 115 ROE: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 162
9.4 ASIA PACIFIC 163
9.4.1 ASIA PACIFIC: IMPACT OF COVID-19 ON THE LAPAROSCOPIC INSTRUMENTS MARKET 163
FIGURE 39 APAC: LAPAROSCOPIC INSTRUMENTS MARKET SNAPSHOT 164
TABLE 116 APAC: LAPAROSCOPIC INSTRUMENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 165
TABLE 117 APAC: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 165
TABLE 118 APAC: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 165
TABLE 119 APAC: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 166
TABLE 120 APAC: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 166
9.4.2 JAPAN 166
9.4.2.1 Supportive reimbursement policies to drive market growth in Japan 166
TABLE 121 JAPAN: KEY MACROINDICATORS 167
TABLE 122 JAPAN: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 167
TABLE 123 JAPAN: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 168
TABLE 124 JAPAN: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 168
TABLE 125 JAPAN: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 168
 
9.4.3 CHINA 169
9.4.3.1 Large patient population and healthcare infrastructure improvements to drive the market growth in China 169
TABLE 126 CHINA: KEY MACROINDICATORS 169
TABLE 127 CHINA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 170
TABLE 128 CHINA: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 170
TABLE 129 CHINA: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 171
TABLE 130 CHINA: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 171
9.4.4 INDIA 171
9.4.4.1 Healthcare infrastructural improvements and implementation of favorable government initiatives support the market in India 171
TABLE 131 INDIA: KEY MACROINDICATORS 172
TABLE 132 INDIA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 172
TABLE 133 INDIA: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 134 INDIA: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 173
TABLE 135 INDIA: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 173
9.4.5 REST OF APAC 174
TABLE 136 ROAPAC: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 174
TABLE 137 ROAPAC: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 138 ROAPAC: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 175
TABLE 139 ROAPAC: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 175
9.5 LATIN AMERICA 176
TABLE 140 LATIN AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 176
TABLE 141 LATIN AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 176
TABLE 142 LATIN AMERICA: LAPAROSCOPES MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 143 LATIN AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 177
TABLE 144 LATIN AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION) 177
9.5.1 BRAZIL 178
9.5.1.1 Brazil dominates the laparoscopic instruments market in Latin America 178
TABLE 145 BRAZIL: KEY MACROINDICATORS 178
TABLE 146 BRAZIL: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 178
TABLE 147 BRAZIL: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 148 BRAZIL: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 179
TABLE 149 BRAZIL: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 179
9.5.2 MEXICO 180
9.5.2.1 Increasing incidence of lifestyle-related disorders and increasing awareness drive market growth in Mexico 180
TABLE 150 MEXICO: KEY MACROINDICATORS 180
TABLE 151 MEXICO: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 181
TABLE 152 MEXICO: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 181
TABLE 153 MEXICO: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 182
TABLE 154 MEXICO: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 182
9.5.3 REST OF LATIN AMERICA 182
TABLE 155 ROLA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 183
TABLE 156 ROLA: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 157 ROLA: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 184
TABLE 158 ROLA: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 184
9.6 MIDDLE EAST AND AFRICA 184
9.6.1 INITIATIVES TO ENHANCE HEALTHCARE ACCESSIBILITY MAY SUPPORT MARKET GROWTH 184
TABLE 159 MEA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 185
TABLE 160 MEA: LAPAROSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 185
TABLE 161 MEA: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 186
TABLE 162 MEA: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 186
10 COMPETITIVE LANDSCAPE 187
10.1 OVERVIEW 187
10.2 KEY PLAYER STRATEGIES 187
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 188
FIGURE 40 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE LAPAROSCOPIC INSTRUMENTS MARKET 188
10.4 MARKET SHARE ANALYSIS 188
FIGURE 41 LAPAROSCOPIC INSTRUMENTS MARKET SHARE, BY KEY PLAYER, 2020 189
10.5 COMPETITIVE LEADERSHIP MAPPING 190
10.5.1 STARS 191
10.5.2 EMERGING LEADERS 191
10.5.3 PERVASIVE PLAYERS 191
10.5.4 PARTICIPANTS 191
FIGURE 42 LAPAROSCOPIC INSTRUMENTS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 192
10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS 193
10.6.1 PROGRESSIVE COMPANIES 193
10.6.2 DYNAMIC COMPANIES 193
10.6.3 STARTING BLOCKS 193
10.6.4 RESPONSIVE COMPANIES 193
FIGURE 43 LAPAROSCOPIC INSTRUMENTS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2020) 194
10.7 COMPANY PRODUCT FOOTPRINT 195
FIGURE 44 PRODUCT PORTFOLIO ANALYSIS: LAPAROSCOPIC INSTRUMENTS MARKET 195
10.8 GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE LAPAROSCOPIC INSTRUMENTS MARKET 196
FIGURE 45 GEOGRAPHIC REVENUE MIX: LAPAROSCOPIC INSTRUMENTS MARKET (2020) 196
10.9 COMPETITIVE SCENARIO 197
TABLE 163 PRODUCT LAUNCHES (2017–FEBRUARY 2021) 197
TABLE 164 DEALS (2017–2020) 198
11 COMPANY PROFILES 199
11.1 KEY PLAYERS 199
(Business overview, Products offered, Recent Developments, Strategic overview, SWOT Analysis, MNM view)*
11.1.1 INTUITIVE SURGICAL, INC. 199
TABLE 165 INTUITIVE SURGICAL, INC.: BUSINESS OVERVIEW 199
FIGURE 46 COMPANY SNAPSHOT: INTUITIVE SURGICAL, INC. (2020) 200
11.1.2 ETHICON, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.) 204
TABLE 166 JOHNSON & JOHNSON: BUSINESS OVERVIEW 204
FIGURE 47 COMPANY SNAPSHOT: JOHNSON & JOHNSON (2020) 205
11.1.3 OLYMPUS CORPORATION 209
TABLE 167 OLYMPUS CORPORATION: BUSINESS OVERVIEW 209
FIGURE 48 COMPANY SNAPSHOT: OLYMPUS CORPORATION (2020) 210
11.1.4 MEDTRONIC PLC 214
TABLE 168 MEDTRONIC PLC: BUSINESS OVERVIEW 214
FIGURE 49 COMPANY SNAPSHOT: MEDTRONIC PLC (2019) 215
11.1.5 STRYKER CORPORATION 219
TABLE 169 STRYKER CORPORATION: BUSINESS OVERVIEW 219
FIGURE 50 COMPANY SNAPSHOT: STRYKER CORPORATION (2019) 220
11.1.6 B. BRAUN MELSUNGEN AG 223
TABLE 170 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW 223
FIGURE 51 COMPANY SNAPSHOT: B. BRAUN MELSUNGEN AG (2019) 224
11.1.7 CONMED CORPORATION 226
TABLE 171 CONMED CORPORATION: BUSINESS OVERVIEW 226
FIGURE 52 COMPANY SNAPSHOT: CONMED CORPORATION (2020) 227
11.1.8 BECTON, DICKINSON AND COMPANY 230
TABLE 172 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 230
FIGURE 53 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY (2020) 231
11.1.9 SMITH & NEPHEW PLC 233
TABLE 173 SMITH & NEPHEW PLC: BUSINESS OVERVIEW 233
FIGURE 54 COMPANY SNAPSHOT: SMITH & NEPHEW PLC (2020) 234
11.1.10 MICROLINE SURGICAL, INC. (A SUBSIDIARY OF HOYA CORPORATION) 235
TABLE 174 MICROLINE SURGICAL, INC.: BUSINESS OVERVIEW 235
FIGURE 55 HOYA CORPORATION: COMPANY SNAPSHOT (2020) 236
11.1.11 KARL STORZ GMBH & CO. 238
TABLE 175 KARL STORZ GMBH & CO.: BUSINESS OVERVIEW 238
11.1.12 RICHARD WOLF GMBH 240
TABLE 176 RICHARD WOLF GMBH: BUSINESS OVERVIEW 240
11.1.13 MINDRAY MEDICAL INTERNATIONAL LIMITED 242
TABLE 177 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW 242
11.1.14 COOK MEDICAL INC. 243
TABLE 178 COOK MEDICAL INC.: BUSINESS OVERVIEW 243
11.1.15 SCHÖLLY FIBEROPTIC GMBH 244
TABLE 179 SCHÖLLY FIBEROPTIC GMBH: BUSINESS OVERVIEW 244
11.2 OTHER PLAYERS 245
11.2.1 OPTOMIC 245
TABLE 180 OPTOMIC: BUSINESS OVERVIEW 245
11.2.2 VICTOR MEDICAL INSTRUMENTS CO., LTD. 246
TABLE 181 VICTOR MEDICAL INSTRUMENTS CO., LTD.: BUSINESS OVERVIEW 246
11.2.3 PETERS SURGICAL 247
TABLE 182 PETERS SURGICAL: BUSINESS OVERVIEW 247
11.2.4 ENDOMED SYSTEMS GMBH 248
TABLE 183 ENDOMED SYSTEMS GMBH: BUSINESS OVERVIEW 248
11.2.5 STRAUSS SURGICAL 249
TABLE 184 STRAUSS SURGICAL: BUSINESS OVERVIEW 249
11.2.6 AMNOTEC INTERNATIONAL MEDICAL 250
TABLE 185 AMNOTEC INTERNATIONAL MEDICAL: BUSINESS OVERVIEW 250
*Details on Business overview, Products offered, Recent Developments, Strategic overview, SWOT Analysis, MNM view might not be captured in case of unlisted companies.
 
12 APPENDIX 251
12.1 DISCUSSION GUIDE 251
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 255
12.3 AVAILABLE CUSTOMIZATIONS 257
12.4 RELATED REPORTS 257
12.5 AUTHOR DETAILS 258

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127